iPS cells are moving from clinical trialsーeye disease, Parkinson’s disease, heart failure, cancer, spinal cord injuriesーto the stage of practical application.
Few manufacturers — such as Japan’s Eisai and the U.S.’ Biogen — have continued to develop a treatment. We hope the health ministry announces the approval...
Graduate student’s study of how sea slugs regenerate their lost, damaged or cut-off parts can be unraveled could bring new hope to regenerative medicine for humans.
iPS cell research is moving ahead quickly with promising applications for COVID-19, diseases affecting vision and muscular function, among others. The issue to overcome next is...
Getting started with the world of ukiyo-e can feel a bit daunting. After all, how does one even begin to understand the art of...
